Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Clinical trial NCT07116746 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07116746
Sponsor: Arthrosi Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gout Gouty Arthritis Hyperuricemia Gout Chronic Refractory Gout Uncontrolled Gout Tophaceous Gout

Start date: 2025-12-03
Primary completion: 2026-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.